BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Farzand S, Siddique T, Saba K, Bukhari MH. Frequency of HER2/neu overexpression in adenocarcinoma of the gastrointestinal system. World J Gastroenterol 2014; 20(19): 5889-5896 [PMID: 24914350 DOI: 10.3748/wjg.v20.i19.5889]
URL: https://www.wjgnet.com/1007-9327/full/v20/i19/5889.htm
Number Citing Articles
1
Heba A. Sayed, Abeer Refaiy, Mohammed A. Salem. Prognostic Impact of HER/2 Expression on Survival of Preoperatively Treated Children with Wilms Tumor at South EgyptJournal of Cancer Therapy 2017; 8(09): 801 doi: 10.4236/jct.2017.89070
2
Susnata Khan, Senjuti Dasgupta, Asit Ranjan Deb. Colorectal Carcinoma: Is There Any Correlation between Her2/neu Expression, Ki-67 Score, and Tumor Budding and Clinicopathological Parameters?—A Prospective Institution-Based StudySouth Asian Journal of Cancer 2024;  doi: 10.1055/s-0044-1789276
3
Renuka Patil, Shanthala P R, Prema Saldanha. IMMUNOHISTOCHEMICAL MARKERS OF CLINICAL SIGNIFICANCE IN CARCINOMA OF THE COLON AND RECTUMJournal of Evolution of Medical and Dental Sciences 2016; 5(96): 7087 doi: 10.14260/jemds/2016/1603
4
Danielle Benedict Sacdalan, Marvin Jonne Mendoza, John Paulo Vergara, Lance Isidore Catedral, Frederic Ivan Ting, Louis Mervyn Leones, Carlo Miguel Berba, Dennis L. Sacdalan. Beyond bevacizumab: a review of targeted agents in metastatic small bowel adenocarcinomaMedical Oncology 2020; 37(11) doi: 10.1007/s12032-020-01432-3
5
Jung-Soo Pyo, Guhyun Kang, Kyeongmee Park. Clinicopathological Significance and Diagnostic Accuracy of HER2 Immunohistochemistry in Colorectal Cancer: A Meta-AnalysisThe International Journal of Biological Markers 2016; 31(4): 389 doi: 10.5301/jbm.5000208
6
Valentina Fanotto, Elena Ongaro, Karim Rihawi, Antonio Avallone, Nicola Silvestris, Lorenzo Fornaro, Enrico Vasile, Lorenzo Antonuzzo, Francesco Leone, Gerardo Rosati, Francesco Giuliani, Roberto Bordonaro, Mario Scartozzi, Giovanna De Maglio, Francesca V. Negri, Gianpiero Fasola, Giuseppe Aprile. HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectivesOncotarget 2016; 7(42): 69060 doi: 10.18632/oncotarget.11264
7
Shipra Singh, Kailash Chand Jat, Ajit Singh, Kunal Purohit. A STUDY OF HISTOPATHOLOGICAL DISTRIBUTION IN COLORECTAL CANCERINTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2021; : 24 doi: 10.36106/ijsr/0306321
8
Seyed-Hamid Madani, Edris Sadeghi, Akram Rezaee, Masoud Sadeghi, Sedigheh Khazaee, Nasrin Amirifard, Mehrdad Payandeh. Survey of HER2-neu Expression in Colonic Adenocarcinoma in the West of IranAsian Pacific Journal of Cancer Prevention 2015; 16(17): 7671 doi: 10.7314/APJCP.2015.16.17.7671
9
Asma Shabbir, Talat Mirza, Abdullah Bin Khalid, Muhammad Asif Qureshi, Sadaf Ahmed Asim. Frequency of Her2/neu expression in colorectal adenocarcinoma: a study from developing South Asian CountryBMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2912-y
10
Peng Ye, Fanghua Li, Yuanyuan Wei, Yihao Zhang, Jianing Cui, Rui Dai, Hao Chen, Jing Xie, Peiling Cai. EGFR, HER2, and HER3 protein expression in paired primary tumor and lymph node metastasis of colorectal cancerScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-17210-2
11
Ritu Jangir, Ajay Sharma, Anjali Sharma, Rateesh Sareen. STUDY OF HER2 NEU POSITIVITY IN GASTROINTESTINAL CANCERS AT A TERTIARY CARE HOSPITAL IN INDIAINTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2021; : 7 doi: 10.36106/ijsr/7517525
12
Anna La Salvia, Victoria Lopez-Gomez, Rocio Garcia-Carbonero. HER2-targeted therapy: an emerging strategy in advanced colorectal cancerExpert Opinion on Investigational Drugs 2019; 28(1): 29 doi: 10.1080/13543784.2019.1555583
13
Serkan Yaşar ÇELİK, Leyla TEKİN. Kolorektal Kanserlerde HER-2/neu Ekspresyonunun Histopatolojik ve Prognostik Parametrelerle KorelasyonuMuğla Sıtkı Koçman Üniversitesi Tıp Dergisi 2020; 7(3): 145 doi: 10.47572/muskutd.767857
14
Zeinab Faghfoori, Bahram Pourghassem Gargari, Amir Saber, Maryam Seyyedi, Siavash Fazelian, Ahmad Yari Khosroushahi. Prophylactic effects of secretion metabolites of dairy lactobacilli through downregulation of ErbB-2 and ErbB-3 genes on colon cancer cellsEuropean Journal of Cancer Prevention 2020; 29(3): 201 doi: 10.1097/CEJ.0000000000000393
15
Harshabad Singh, Ashley Kang, Lisa Bloudek, Ling-I Hsu, Maria Corinna Palanca-Wessels, Michael Stecher, Muriel Siadak, Kimmie Ng. Systematic literature review and meta-analysis of HER2 amplification, overexpression, and positivity in colorectal cancerJNCI Cancer Spectrum 2024; 8(1) doi: 10.1093/jncics/pkad082